JOURNAL ONKOLOGIE – STUDIE
Adrenal Tumors - Pathogenesis and Therapy
Rekrutierend
NCT-Nummer:
NCT00669266
Studienbeginn:
September 2002
Letztes Update:
28.08.2018
Wirkstoff:
-
Indikation (Clinical Trials):
Syndrome, Pheochromocytoma, Cushing Syndrome, Adrenocortical Carcinoma, Adrenal Gland Neoplasms, Hyperaldosteronism
Geschlecht:
Alle
Altersgruppe:
Alle
Phase:
-
Sponsor:
University of Wuerzburg
Collaborator:
Deutsche Krebshilfe e.V., Bonn (Germany), German Federal Ministry of Education and Research,
Studienleiter
Principal Investigator
U of Wuerzburg
Kontakt
Kontakt:
Phone: 49-931-201-36507
E-Mail: fassnacht_m@medizin.uni-wuerzburg.de» Kontaktdaten anzeigen
Studienlocations
(1 von 1)
97080 Wuerzburg
(Bayern)
GermanyRekrutierend» Google-Maps
Ansprechpartner:
Martin Fassnacht, MD
E-Mail: fassnacht_m@medizin.uni-wuerzburg.de
Stefanie Hahner, MD
E-Mail: hahner_s@medizin.uni-wuerzburg.de» Ansprechpartner anzeigen
Studien-Informationen
Brief Summary:The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.
Ein-/Ausschlusskriterien
Inclusion Criteria:- adrenal tumor detected by imaging
Exclusion Criteria:
Studien-Arme
- Tumor
Tumor material and corresponding biosamples from patients with adrenal tumors - control group
Biomaterial from patients without adrenal tumor
Quelle: ClinicalTrials.gov
Das könnte Sie auch interessieren